2160 GIV as a novel marker of recurrence risk in MMR proficient stage II colon cancer. (September 2015) - Gibbs, P; Tie, J.; Ghosh, P; Muranyi, A.; Brunhoeber, P; Singh, S.; LaFluer, B.; Xu, C.; Leith, K.; Tran, B.; Desai, J.; Martinez, R.; et al.